Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Revenues:
License revenue, net	$ 0	$ 2,125,000	$ 0	$ 2,125,000
Laboratory revenues, net	355,562	69,888	678,700	129,927
Total Revenues	355,562	2,194,888	678,700	2,254,927
Operating Costs and Expenses:
General and administrative	694,281	662,627	1,967,817	1,398,456
Research and development	279,641	426,572	511,959	733,722
Costs of laboratory services	301,142	132,406	545,000	237,825
Total Operating Costs and Expenses	1,275,064	1,221,605	3,024,776	2,370,003
Loss from Operations	(919,502)	973,283	(2,346,076)	(115,076)
Other Income (Expense):
Warrant expense	(775,996)	0	(1,491,996)	0
Change in fair value of warrant liability	16,386	0	(77,471)	0
Other income (expense)	(783)	6,499	49,187	7,336
Total Other Income (Expense), net	(760,393)	6,499	(1,520,280)	7,336
Net Income (Loss)	$ (1,679,895)	$ 979,782	$ (3,866,356)	$ (107,740)
Net Income (Loss) Per Share - Basic (in dollars per share)	$ (0.06)	$ 0.05	$ (0.15)	$ 0
Weighted average number of common shares outstanding during the period - Basic (in shares)	27,885,479	21,706,472	26,560,448	21,633,985
Net Income (Loss) Per Share - Dilutive (in dollars per share)	$ (0.06)	$ 0.05	$ (0.15)	$ 0
Weighted average number of common shares outstanding during the period - Dilutive (in shares)	27,885,479	21,883,414	26,560,448	23,782,010